Description
An inhibitor of mutant IDH1 (IC50s = 9, 15, and 17 nM for IDH1 mutants R132C, R132H, and R132G, respectively); causes a dose-dependent reduction in 2-hydroxyglutarate and overcomes the block of differentiation in AML cells expressing mutant IDH1
Formal name: (S)-1-(4-fluorobenzyl)-N3-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3,7-dicarboxamide
Synonyms:
Molecular weight: 558.6
CAS: 1816331-66-4
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cancer||Research Area|Cell Biology|Mitochondrial Biology